EP0891179B1 - A system, method and device for controllably releasing a product - Google Patents

A system, method and device for controllably releasing a product Download PDF

Info

Publication number
EP0891179B1
EP0891179B1 EP97912944A EP97912944A EP0891179B1 EP 0891179 B1 EP0891179 B1 EP 0891179B1 EP 97912944 A EP97912944 A EP 97912944A EP 97912944 A EP97912944 A EP 97912944A EP 0891179 B1 EP0891179 B1 EP 0891179B1
Authority
EP
European Patent Office
Prior art keywords
interior
container
plug member
component
cap member
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP97912944A
Other languages
German (de)
French (fr)
Other versions
EP0891179A1 (en
Inventor
Chuan Qin
Yuanpang Samuel Ding
Chi Chen
Jerry Ripley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Publication of EP0891179A1 publication Critical patent/EP0891179A1/en
Application granted granted Critical
Publication of EP0891179B1 publication Critical patent/EP0891179B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/32Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
    • B65D81/3216Rigid containers disposed one within the other
    • B65D81/3222Rigid containers disposed one within the other with additional means facilitating admixture
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00Fluid handling
    • Y10T137/1842Ambient condition change responsive
    • Y10T137/1939Atmospheric
    • Y10T137/1963Temperature
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00Fluid handling
    • Y10T137/1842Ambient condition change responsive
    • Y10T137/1939Atmospheric
    • Y10T137/2012Pressure

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • External Artificial Organs (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicinal Preparation (AREA)

Description

    BACKGROUND OF THE INVENTION
  • The present invention generally relates to a system for release of a product into the system following occurrence of an event. More specifically, the present invention relates to a system and a method for controllable release of a product which requires separation from a remainder of the products contained in a system.
  • A major function of a kidney is to maintain an acid-based homeostasis in the body. A patient requiring renal dialysis relies on a buffer provided in a dialysate for this function. A natural buffer which is present in the body is a bicarbonate buffer. Therefore, using a bicarbonate buffer is a natural choice for combination with a dialysate. However, bicarbonate when mixed with dextrose contained in dialysate causes the dextrose to degrade at the high temperatures that are used during autoclaving. Therefore, lactate has often been used as a substitute for bicarbonate.
  • Solution biocompatability is, of course, a major concern in dialysis. Therefore, combining dialysate with a bicarbonate buffer has been seriously pursued. Accordingly, many endeavors have been undertaken to develop a bicarbonate solution for use in dialysis.
  • One such known method is to incorporate a dual-chamber bag. In this system and method, two solutions are contained in two separate chambers of a bag that are integrally formed. Between the chambers of the bag is a frangible. When the frangible is broken, the two solutions are admixed. However, such a system is difficult to manufacture, and the material costs required to produce the dual-chamber bag are high.
  • Of course, a number of other applications require separation of components prior to use due to compatibility issues. For example, a number of intravenous solutions require separation, such as dextrose and heparin, chemotherapy drugs and antibiotic drugs. Other peritoneal dialysis solutions also require separation besides dextrose and a buffer, such as polyglucose and a buffer; dextrose or polyglucose and a peptide or amino acids; and Dianeal® and heparin.
  • EP-A-0597111 discloses a canned food or beverage container comprising a capsule body position inside a can. Powdered or solid contents from the capsule body are released into a liquid in the can upon an increase in the internal pressure of the capsule body.
  • US-A-2,371,774 discloses a device for dispensing pharmaceutical preparations comprising a cartridge containing a powdered form of a drug inside a glass bottle. The contents of the cartridge are released into the bottle when the internal pressure of the cartridge is increased. WO-A-95/32130 discloses a beverage container comprising a hollow insert containing a first liquid positioned inside a can containing a second liquid. The two liquids are mixed when a closure portion on the insert is released due to an increase in pressure within the insert.
  • A need, therefore, exists for an improved device, system and method for controllably releasing a component, such as bicarbonate, into a solution or second component for mixing of the component with the solution.
  • SUMMARY OF THE INVENTION
  • According to the present invention there is provided a system according to claims 1 and 7 and a method according to claims 15 and 16 for controllably releasing a component. The system of the present invention typically sealingly holds the component until a predetermined event, such as a change, in an external condition, occurs causing release of the component into another container having a solution therein. As a result, the component is mixed with the solution.
  • Thus, the present invention provides a system for controlling release of a component. The system has a container having walls defining an interior capable of holding a product therein wherein the product requires mixture with the component. A device exposed to the interior of the container has walls defining an interior. A plug member encloses the interior wherein the interior holds the component for mixing with the product in the container.
  • In an embodiment, the plug member is constructed from material designed to alter its shape due to changes in temperature.
  • In an embodiment, the plug member is designed in a shape to alter position of the plug member in the device due to variations in pressure.
  • A cap member encloses an end of the device remote from the plug member. A second plug member may be located intermediate the cap member and the plug member in the interior of the device. The second plug member may be designed in a shape that alters its position in the device due to variations in pressure.
  • In an embodiment, the component is a buffer used in a dialysis procedure.
  • In an embodiment, the product is a solution including dextrose.
  • The method for controlling release of an agent. may comprise the steps of: providing a container having an interior capable of holding a product therein; filling a device with the agent; sealing the agent in the device; providing the device in the interior of the container; and altering a condition that is applied to the container so as to cause release of the agent from the device due to the altered condition.
  • In an embodiment, a plug member is provided sized to seal and enclose one end of the device wherein the plug member is responsive to changes in temperature.
  • In an embodiment, a plug member is provided sized to seal and enclose one end of the device wherein the plug member is responsive to changes in pressure.
  • In an embodiment, the agent is a buffer requiring mixture with the product for use in a dialysis procedure.
  • In an embodiment, the product is a solution having dextrose therein.
  • In an embodiment, the temperature is increased to subject the container to sterilization.
  • In another embodiment of the present invention, a device is provided having an agent therein for controllable release of the agent into a system. The device has a wall defining an interior that is accessible via an open end wherein the interior holds the agent. Further, a cap member is sized to seal and enclose the open end wherein the agent is enclosed and sealed in the interior and further wherein the cap member is responsive to a change in an external condition causing alteration of the cap member to release the agent.
  • In an embodiment, a plug member is located remotely from the cap member wherein the plug member is responsive to the change in the external condition. The cap member and the plug member are shaped to respond to changes in pressure. The cap member and the plug member may further be distinctly shaped from each other.
  • In an embodiment, the cap member has a core and a shell each made of distinct materials wherein each material reacts differently in changing temperature conditions.
  • In an embodiment, the agent is a buffer requiring mixture with a solution prior to administration to a patient undergoing a dialysis procedure.
  • In an embodiment, the external condition is varying pressure.
  • In an embodiment, the external condition is varying temperature.
  • In an embodiment, the wall has an integrally formed surface directed to the interior.
  • It is, therefore, an advantage of the present invention to provide a device, a system and a method for separating at least two components.
  • Another advantage of the present invention is to provide a device, a system and a method for simplifying separation of at least two components.
  • Yet another advantage of the present invention is to provide a device, a system and a method for controllably releasing a component into another component.
  • A still further advantage of the present invention is to provide a cost effective device, system and method for separating at least two components and controllably releasing at least one component into another component.
  • Moreover, an advantage of the present invention is to provide a device, a system and a method that automatically releases one component into another component during normal use of the system.
  • And, another advantage of the present invention is to provide a device, a system and a method that reliably maintains separation between at least two components and also reliably controls release of one component into at least one other component.
  • Yet another advantage of the present invention is to provide a device, a system and a method for controllably releasing a component into another component that is simple for a customer to use.
  • A still further advantage of the present invention is to provide a device, a system and a method for controllably releasing a component that is inexpensive to manufacture and to implement.
  • Additional features and advantages of the present invention are described in, and will be apparent from, the detailed description of the presently preferred embodiments and from the drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • Figure 1 illustrates a plan view of an embodiment of a solution container having a controllable release device therein in an embodiment of the present invention.
  • Figure 2 illustrates a plan view of an embodiment of a controllable release device of the present invention.
  • Figure 3 illustrates an alternate embodiment of a controllable release device in a first position in an embodiment of the present invention.
  • Figure 4 illustrates a plan view of an alternate embodiment of the controllable release device of Figure 3 in a second position in an embodiment of the present invention.
  • Figure 5 illustrates a cross-sectional view of an embodiment of a plug member as used in a device in an embodiment of the present invention.
  • Figure 6 illustrates a cross-sectional view of another embodiment of a plug member as used in a device in an embodiment of the present invention.
  • Figure 7 illustrates a cross-sectional view of yet another embodiment of a plug member used in a device in an embodiment of the present invention.
  • Figure 8 illustrates a cross-sectional view of yet another embodiment of a plug member used in a device in an embodiment of the present invention.
  • Figure 9 illustrates a cross-sectional view of yet another embodiment of a plug member used in a device in an embodiment of the present invention.
  • Figure 10 illustrates a cross-sectional view of a process for controllably releasing material from a device in an embodiment of the present invention.
  • Figure 11 illustrates a perspective view showing a process for forming a gap in another embodiment of a valve member for a device in an embodiment of the present invention.
  • Figure 12 illustrates a perspective view showing a process for forming a gap in yet another embodiment of a valve member for a device in an embodiment of the present invention.
  • Figure 13 illustrates a graph demonstrating the effect of temperature and pressure in an embodiment of the system of the present invention.
  • Figures 14(A)-14(I) illustrate alternate views of embodiments of controllable release devices.
  • Figure 15 illustrates a schematic diagram of an embodiment of a thermal valve device of the present invention.
  • DETAILED DESCRIPTION OF THE PRESENTLY PREFERRED EMBODIMENTS
  • The present invention generally relates to a controllable release valve or device, a system and a method for controllably releasing a product into another product. The system is particularly applicable for use in controllably releasing a component into a non-compatible component prior to use of the combined components. Such a system is particularly useful in a dialysis procedure wherein a device is provided containing sodium bicarbonate which must be maintained separately from a solution containing dextrose as sodium bicarbonate causes degradation of dextrose at high temperatures.
  • Referring now to the drawings wherein like numerals refer to like parts, Figure 1 generally illustrates a container 10 having a device 12 of the present invention therein. The container 10 has an interior 14 formed by exterior walls 16. Typically, the walls 16 of the container are a thermoplastic material, but any material for the walls 16 are within the scope of the present invention. The interior 14 of the container 10 is capable of holding a solution or other component therein.
  • The device 12, as illustrated, is loosely suspended within the interior 14 of the container 10. However, it should be appreciated that the device 12 may be attached by a hanging mechanism (not shown) such that the device 12 is removably held in the interior 14 of the container 10. The container 10, as illustrated, includes two ports 18 providing fluid communication with the interior 14 of the container 10. Of course, a single port 18 or additional ports may be provided as required for the particular embodiment in which the invention is used.
  • The device 12, as illustrated in Figure 1, is a hydrostatic valve designed with two plug members 20a, 20b and a cap member 22. The plug members 20a, 20b, as illustrated, are designed having distinct shapes such that each operates slightly different under varying temperature and/or pressure conditions. Of course, it should be appreciated that a single plug 20' may also be implemented as will be described with reference to Figure 2 or, alternatively, additional plugs may also be implemented. The plug members 20a, 20b may also be identically shaped for a particular application in which the same may be appropriate. In addition, the cap member 22 may be connected to the plug member 20a such that when the cap member 22 is forced from the device 12, as illustrated in Figure 4, the cap member 22 does not randomly release into the interior 14 of the container 10. To this end, a connecting member 21 may be provided that maintains the cap member 22 in spaced relation to the plug member 20a.
  • The device 12 has an interior section 24 in which a product 26, such as, for example, a buffer, may be stored prior to admixture with a component in the interior 14 of the container 10. During manufacture, the device 12 containing the product 26 may be inserted into the container 10 during a container forming process. The container 10 is then filled with a solution in the interior 14 of the container 10 containing all of the necessary ingredients required for a procedure, such as peritoneal dialysis. As previously mentioned, the device 12 may be floating or fixed within the interior 14 of the container 10.
  • The product 26, either in solid or in liquid form, is, therefore, sealed inside the device 12 and isolated from the bulk of the solution within the interior 14 of the container 10. The container 10 may then be separately pouched in an overpouch as required for the particular application. The container 10, with or without the overpouch, may then be autoclaved or heat sterilized as required.
  • During a sterilization procedure, the dynamics of the device 12 takes place. To prevent the container from exploding, an overpressure is required within an autoclave chamber in a standard autoclave cycle during which time the temperature within the chamber is raised. The overpressure compresses the device 12 thereby pushing the plug members 20a, 20b toward the cap member 22. Under compression, the seal is maintained between a product 26 and the solution in the interior 14 of the container 10.
  • At the completion of the cycle, pressure drops after the chamber is cooled off. When chamber pressure decreases, pressure inside the device 12 becomes greater than an exterior pressure. Then, internal pressure within the interior section 24 of the device 12 becomes so strong so as to push off the cap member 22 and release the product 26 into the interior 14 of the container 10 to mix with the solution contained therein. The admixing thereby occurs automatically at a cooler temperature, and the interaction between the product 26 and the solution is prevented during heat sterilization or the autoclave cycle in which it is not possible to mix the solution in the interior 14 of the container 10 with the product 26 in the interior section 24 of the device 12.
  • The above-described process is clearly illustrated with reference to the graph of Figure 13. As shown from the graph, the plug member and cap member react due to changes in pressure conditions in the system during the autoclave cycle. In addition, the plug member 20b is designed such that the friction with the walls of the device exceeds the friction from the cap member 22 containing the product 26 and any additional plug members between the cap member and the most extreme plug member 20a. In addition, both the plug member and the cap member may be designed as one way plugs such that movement of the plug members and the cap member only occurs in a single direction.
  • Referring again to the graph of Figure 13, two separate activations are required in order for the cap member 22 to be removed from the device 12. Namely, during the autoclave cycle, when external pressure is large, the plug member 20 is pushed inward into the device 12. During cooling, the internal pressure becomes greater forcing the cap member 22 to pop out thereby releasing the component 26 contained in the device 22. The component 26 is thereby released into the interior 14 of the container 10. As previously mentioned, the plug member 20 and the cap member 22 may be connected such that the cap member 22 does not stray from the device 12 in the interior 14 of the container 10.
  • In a preferred embodiment, the plug and cap members 20a, 20b and 22, 20b are made from silicon elastomer. Using the additional plug member 20a at a middle point of the device 12, both of the plug members 20a, 20b move toward the cap member 22 the same way as one plug member moves within the device 12. With the additional plug member 20a, a better seal may be achieved and a physical push to cap member 22 can be generated.
  • Referring now to Figures 2, a single plug member 20' is shown within a device 12' with a cap member 22' enclosing an interior section 24' in which a product 26' is sealed therein. The device operates in a similar manner as the two plug member design except that an extra plug member is not provided to maintain the integrity of the seal. In a preferred embodiment, the plug member may be constructed from a polyvinylchloride (PVC) material. Of course, other materials may be implemented by those skilled in the art.
  • Figures 3 and 4 illustrate the device 12 as described with reference to Figure 1 incorporating the dual plug members 20a, 20b within the interior 24 of the device 12. Again, a single cap 22 encloses the interior of the container and is constructed such that a seal is maintained between an end 25 of the device 12 maintaining the product 26 within the interior section 24 of the device 12. During cooling of the device, pressure inside the device 12 becomes stronger thereby forcing removal of the cap member 22 from the end 25 of the device 12 and thereby allowing the product 26 to escape from the device 12. As previously stated, the plug member 20 also advances within the interior 24 of the device 12 maintaining the integrity of the seal from an opposite end of the cap member 22.
  • The hydrostatic valve design shown and described in Figures 2-4 and further shown and described with reference to Figures 5-10 is designed for processes which undergo pressure difference cycles, such as, for example, autoclave sterilization cycles under overpressure conditions. The activation member for opening the valve or plug member 20 or the cap member 22 is the volume expansion of air by pressure differences. The device 12 as previously described including the cap member 22 is designed to be incapable of moving into the device 12 under high external pressure, but opens under high internal pressure. The moving part or plug member 20, 20a and/or 20b is designed such that the plug member only moves within the device 12 under high external pressure but does not move out as easily as the cap member during high internal pressure. In addition, as previously described, the plug member 20 and the cap member 22 are designed such that the friction in the most distant plug member from the cap member exceeds the friction of the other plug members, if any, and the cap member 22.
  • Further, friction forces between the walls of the device 12 and the plug member 20, 20a and/or 20b and the cap member 22 are critical since the friction forces dominate both compression and expansion processes, i.e. less friction force for the cap member 22 (at least less than the expansion force on the cap member 22) and a higher friction force for the plug member 20, 20a and/or 20b during the opening process. A higher friction force is required for the cap member 22 and a lesser friction force is required for the plug member 20, 20a and/or 20b during a compression process. The friction forces can be controlled by a proper choice of material and the specific designs of the plug member 20, 20a and/or 20b and the cap member 22. The interfacial friction forces also contribute to the degree of sealing between the walls of the device 12 and the plug member 20, 20a and/or 20b and the cap member 22.
  • As illustrated in Figures 5-9, different design shapes of the plug members 20 are illustrated, either for the single plug design or the double plug design. The shape of the plug member 20 is designed for easy opening of the hydrostatic valves. For some products 26 contained in the device 12, for example, certain drugs, their dissolution rate in water is controlled by device shapes and wetability which dictate the contact between water and drugs. The improvement in surface hydrophilicity of the device 12 should be helpful to dissolve the contained drug into water by increasing the contact area between water and the drugs. Some surface modification treatments have been employed for this purpose, such as plasma treatment of the surfaces of the device 12; inorganic acid treatment of internal surfaces of the device 12; blending a water-soluble polymer into shell materials to improve surface wetability; and coextruding a hydrophilic layer on the internal surface of the devices. These surface treatments improve the surface hydrophilicity.
  • As illustrated in Figures 5-9, the different designs of the plug member 20 allow movement of the plug member 20 within the device 12 in the direction of the arrow, but not in the direction of the oppositely directed arrow having an "X" therethrough. As further illustrated in Figure 9, an interior wall of the device 12 may be formed with a ramp 13. The ramp 13 may be integrally formed and is designed as a stopping member, i.e. to stop back-off or return of the plug member 20 in the device 12 during external pressure releasing. Of course, any of the other embodiments of the device 12 may also implement the ramp 13. The ramp 13, however, may simply be replaced by an indent or deformation formed in the wall of the device 12.
  • Figure 10 illustrates the effects of both pressure and temperature within the device 12 to the cap member 22 and the plug member 20. The process of movement of the plug member 20 and subsequent movement of the cap member 22 from changing pressure conditions has been previously described with reference to Figures 1-4. In Figure 10, the construction of the wall of the device 12 is also designed to collapse during changes in pressure and temperature conditions. As a result, with the plug member 20 designed as shown in Figure 10, the wall of the device 12 collapses to affix the plug member 20 in the device 12 thereby limiting any further movement.
  • Referring now to Figures 11 and 12, alternate embodiments to the embodiments illustrated in Figures 1-10 are shown. In Figures 11 and 12, a thermal valve 100 is illustrated. The thermal valve 100 operates under the principles governed by thermal expansion and contraction between polymer materials during heating and cooling cycles and the different swelling capabilities of polymers in an aqueous environment. The differences in thermal expansion or water swelling between two polymers can generate a significant gap during the heating and cooling cycles from a proper choice of materials for the members of the thermal valve device 100. Proper materials allow a separation or opening of the thermal valve 10 under a small driving force, such as gravity, for example.
  • Figures 11 and 12 illustrate an example of a thermal valve 100 with the thermal expansion/contraction of different kinds of polymer materials. With the change in polymer structure and morphology, a variety of transition behaviors can be used to generate a volume difference during heating and cooling cycles thereby creating a gap between the various materials. As illustrated, two distinct materials form a core 102 and a shell 104.
  • In a first example, as illustrated in Figure 11, shell material transverse deformation results from selection of a shell material of a polymer having a low thermal expansion polymer and a lower mechanical strength against deformation at ultimate use temperature (UUT) as well as a lower water swelling capability. A core polymer is selected having a high thermal expansion polymer, a high elastic modulus, thermoset, high water swelling capability, melting temperature (Tm) or glass transmit temperature (Tg) less than UUT and a higher mechanical strength than the polymer of the shell 104 at UUT.
  • In another example illustrated in Figure 12, a core material is subjected to longitudinal deformation. A polymer is selected for the shell 104 of a low thermal expansion polymer: that is, Tg or Tm is greater than the UUT and has enough mechanical strength at UUT. The polymer of the core material is a high thermal expansion polymer with Tg or Tm less than UUT. As a result, a gap is formed between the edge of the core member and an internal radius of the shell member 104 as shown in Figure 12.
  • As a result of the selection of the proper polymers, a gap is created between the shell 104 and the core 102. The kind and size of the gap can be theoretically predicted by a calculation based on thermal expansion and contraction behavior of specific polymers.
  • Example 1
  • The shell material (polymer S) is assumed to be polypropylene (PP, Tm > 150°C), and the core material (polymer C) is a linear low density polyethylene (LLDPE, Tm < 120°C). The UUT is assumed to be 120°C according to normal autoclave temperature. Therefore, the (Tm) LLDPE < UUT <Tm PP condition can be satisfied. The thermal expansion coefficients for PP and LLDPE within the temperature range of 25 - 120°C are similar (about 10-4) since this temperature range is far higher than their Tg's. It can be reasonably assumed that the volume difference due to thermal expansion may be ignored in this circumstance. That is, the volume difference necessary to generate a thermal gap is solely dependent from crystallization/melting transition of LLDPE. With heating from 25°C to 120°C, LLDPE undergoes a melting transition but PP does not. Hence, LLDPE has a dramatic volume expansion by the change of crystalline phase to amorphous phase. With cooling from 120°C to 25°C, LLDPE undergoes a crystallization transition but PP does not. Thus, LLDPE has a dramatic volume contraction by changing from an amorphous phase to a crystalline phase. And, a gap is created by the volume change of LLDPE during heating/cooling cycles due to a relatively constant volume of PP during this heating/cooling cycle, i.e. a longitudinal deformation of LLDPE producing a thermal gap. The following calculation gives a quantitative estimation of the size of the gap. A schematic presentation of a thermal valve device is used in the calculation as illustrated in Figure 15, where L is the longitudinal thickness of the device, which is the same for the shell and the core, 3.0 mm is used in this case; r is the diameter of the valve, 73 mm is used in this case; x is the gap distance. The densities of crystalline PE and amorphous PE are 1.0 and 0.855, respectively. The crystallinity (Xc) of LLDPE is reasonably cited as 40 wt.%. The core materials (LLDPE) weight is assumed to be 0.11 gram. Therefore, the amorphous volume (Va) and crystalline volume (Vc) of PE can be calculated as: Va = 0.11/0.855 = 0.1287 cm3, and Vc = 0.11/1.0 = 0.1100 cm3. The volume difference between Va and Vc is then: V = Va - Vc = 0.0187 cm3 For Xc = 40 wt.%, the volume of semicrystalline LLDPE can be calculated as: Vc+a = XcVc + (1 - Xc) Va = 0.1212 cm3. Thus, the volume difference between Va+c and Va, which is the total volume to be used to create a thermal gap, is calculated as: Vr = Va - Va+c + 0.007507 cm3 = 7.753 mm3. The following equation is then obtained: Vr = r2L - (r - X)2L where Vr = 7.753 mm3, t = 7.40 mm, L = 4.00 mm. Then, the gap distance x which is generated by heating/cooling cycle can be calculated as 0.055 mm under assumed conditions. This gap is believed to be large enough for the thermal valve opening gravity force.
  • The material selected for use with the thermal valve may be classified into two different kinds:
  • (1) Material matches which can generate core material longitudinal deformation; the polymer of the shell material may be any of the following:
  • Polymer S: PP, PS SAN, PMMA, Nylon polyimids, PC, polysulfones, PCCE, PVF2, Taflon, High T polyesters, their blends, and those polymers whose Tg or Tm is higher than UUT (for autoclave cycle, UUT is 120°C).
  • The polymer of the core material may be any of the following:
    • Polymer C: crosslinked PE, low Tm polyesters, polyethers, isonomers, rubbers, their blends, and those polymers whose Tg or Tm is lower than UUT (or autoclave cycle UUT is 120°C).
    The material matches create shell material transfer deformation wherein polymers of the shell material may be any of the following:
    • Polymer S: PE/PP blends, crosslinked PE, PS, their blends, and those polymers which have low thermal expansion, high permanent set, low mechanical strength against deformation at UUT, low water swelling capability.
    And the polymer of the core material may be any of the following:
    • Polymer C: crosslinked rubbers, PU, other synthetic elastomers, hydrogels, EVOH, their blends, and those polymers which have high thermal expansion, high elastic modulus, high water swelling capability at UUT.
  • Referring to Figures 14(A)-(I), various embodiments of hydrostatic and thermal valves are illustrated. Figures 14(A), 14(C), 14(D), 14(F) and 14(I) illustrate various core (C) and shell (S) embodiments in which the thermal valve theory can be implemented. The proper materials for the core and shell are selected such that the core and the shell react to changing temperatures causing a separation and/or deformation between the shell and the core. As a result, a component that is sealed within the device using the thermal valve with the shell and core can be released into another area.
  • In Figures 14(B), 14(G) and 14(H), various alternate embodiments of a device 100', 100'' and 100''', respectively, implementing the hydrostatic valve principle are shown. Figure 14(E) illustrates an alternated design of a plug member 120'. Figure 14(G) illustrates an embodiment in which the device 100'' of the present invention replaces one port 102'' of a plurality of ports that provide fluid communication with an interior 105 of a container 110.
  • Although the present invention has been described with respect to mixing of drug solutions, the present invention may also be implemented for application in the food and beverage industry. Often, instant food and beverages require a heating process before eating or drinking, and some food ingredients or beverage additives cannot be heated together to avoid spoiling the taste. Instead of inconvenient and time-consuming separate mixing, separate products may be placed in the device 12 of the present invention with a thermal or hydrostatic valve within the device and within the container and, after heating, the customer will receive a ready-to-eat food or drink.
  • It should be understood that various changes and modifications to the presently preferred embodiments described herein will be apparent to those skilled in the art. Such changes and modifications may be made without departing from the scope of the present invention and without diminishing its attendant advantages. It is, therefore, intended that such changes and modifications be covered by the appended claims.

Claims (19)

  1. A system for controllably releasing a component, the system comprising:
    a container (10) having walls defining an interior (14);
    a product in the interior of the container;
    a device (12) within the interior of the container wherein the device has walls defining an interior (24) and wherein the device is free-standing within the interior of the container;
    a component (26) in the interior of the device wherein the product requires mixture with the component;
    a first plug member (20b) enclosing the interior of the device; and
    a cap member (22) enclosing an end of the device remote from the first plug member and shaped to respond to changes in pressure;
       wherein when the pressure in the container is increased the device compresses thereby pushing the first plug member (20b) towards the cap member (22) and when the pressure in the container is decreased the cap member (22) is pushed off the device and the component is released into the interior of the container so as to mix with the product contained therein.
  2. A system according to Claim 1, wherein the first plug member (20b) is designed in a shape to alter its position in the device due to variations in pressure.
  3. A system according to Claim 1 or 2, further comprising a second plug member (20a) located intermediate the cap member (22) and the first plug member (20b) wherein the second plug member is located in the interior of the device.
  4. A system according to Claim 3, wherein the second plug member (20a) is designed in a shape that alters its position in the device due to variations in pressure.
  5. A system according to any one of the preceding claims wherein the cap member (22) is designed to be incapable of moving into the device under high external pressure but which opens under high internal pressure.
  6. A system according to any one of the preceding Claims, wherein the first plug member (20b) and/or the second plug member (20a) is designed so that it moves within the device under high external pressure.
  7. A system for controllably releasing a component, the system comprising:
    a container (10) having walls defining an interior (14);
    a product in the interior of the container;
    a device (12) within the interior of the container wherein the device has walls defining an interior (24) and wherein the device is free-standing within the interior of the container;
    a component (26) in the interior of the device wherein the product requires mixture with the component;
    a first plug member enclosing the interior of the device; and
    a cap member (100) enclosing an end of the device remote from the first plug member and responsive to changes in temperature;
       wherein when the temperature in the container is increased, and subsequently decreased an opening is created in the cap member causing release of the component into the interior of the container so as to mix with the product contained therein.
  8. A system according to Claim 7, wherein the first plug member is responsive to changes in temperature.
  9. A system according to Claim 7 or 8, further comprising a second plug member located intermediate the cap member and the first plug member wherein the second plug member is located in the interior of the device.
  10. A system according to any one of Claims 7 to 9, wherein the cap member (100) comprises a core (102) and a shell (104) each made of distinct materials wherein each material reacts differently in changing temperature conditions.
  11. A system according to Claim 10, wherein a gap is created between the core and the shell during heating and cooling cycles.
  12. A system according to any one of the preceding claims, wherein the component is a buffer used in a dialysis procedure.
  13. A system according to any one of the preceding claims, wherein the product is a solution including dextrose.
  14. A system according to any one of the preceding claims, wherein the cap member and the plug member are distinctly shaped from each other.
  15. A method for controllably releasing a component, the method comprising the steps of:
    providing a system according to any one of Claims 1 to 6; and
    altering the pressure that is applied to the system so as to cause release of the component from the device into the container.
  16. A method for controllably releasing a component, the method comprising the steps of:
    providing a system according to any one of Claims 7 to 11; and
    altering the temperature that is applied to the system so as to cause release of the component from the device into the container.
  17. A method according Claim 15 or Claim 16, wherein the component is a buffer requiring mixture with the product for use in a dialysis procedure.
  18. A method according to any one of Claims 15 to 17, wherein the product is a solution having dextrose therein.
  19. A method according to Claim 16, wherein the temperature is increased in order to subject the container to sterilization.
EP97912944A 1996-10-29 1997-10-28 A system, method and device for controllably releasing a product Expired - Lifetime EP0891179B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US739243 1996-10-29
US08/739,243 US5865308A (en) 1996-10-29 1996-10-29 System, method and device for controllably releasing a product
PCT/US1997/019423 WO1998018425A1 (en) 1996-10-29 1997-10-28 A system, method and device for controllably releasing a product

Publications (2)

Publication Number Publication Date
EP0891179A1 EP0891179A1 (en) 1999-01-20
EP0891179B1 true EP0891179B1 (en) 2002-04-03

Family

ID=24971433

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97912944A Expired - Lifetime EP0891179B1 (en) 1996-10-29 1997-10-28 A system, method and device for controllably releasing a product

Country Status (10)

Country Link
US (1) US5865308A (en)
EP (1) EP0891179B1 (en)
JP (1) JP4132079B2 (en)
KR (1) KR19990076875A (en)
BR (1) BR9706898A (en)
CA (1) CA2241076A1 (en)
DE (1) DE69711610T2 (en)
ES (1) ES2175375T3 (en)
MX (1) MX9805191A (en)
WO (1) WO1998018425A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6615856B2 (en) * 2000-08-04 2003-09-09 Biomicro Systems, Inc. Remote valving for microfluidic flow control
DE20106836U1 (en) * 2001-04-19 2001-09-27 Rpc Bramlage Gmbh Use for pressurized liquid containers, especially beverage containers
DE20119197U1 (en) * 2001-11-29 2003-01-16 Rpc Bramlage Gmbh Use for liquid containers
US7988679B2 (en) * 2003-03-18 2011-08-02 Navilyst Medical, Inc. Pressure responsive slit valve assembly for a plurality of fluids and uses thereof
US7435236B2 (en) 2003-06-27 2008-10-14 Navilyst Medical, Inc. Pressure actuated valve with improved biasing member
US7252652B2 (en) * 2003-08-29 2007-08-07 Boston Scientific Scimed, Inc. Valved catheters including high flow rate catheters
US20050165364A1 (en) * 2004-01-22 2005-07-28 Dimatteo Kristian Valved catheter to bypass connector
US8187234B2 (en) * 2004-01-29 2012-05-29 Navilyst Medical, Inc. Pressure activated safety valve with anti-adherent coating
US9933079B2 (en) 2004-01-29 2018-04-03 Angiodynamics, Inc. Stacked membrane for pressure actuated valve
US8034035B2 (en) 2004-01-29 2011-10-11 Navilyst Medical, Inc. Pressure activated safety valve with high flow slit
US9314608B2 (en) 2004-01-29 2016-04-19 Angiodynamics, Inc Pressure activated safety valve with high flow slit
US8328768B2 (en) * 2005-02-11 2012-12-11 Angiodynamics, Inc Pressure activated safety valve with improved flow characteristics and durability
US8585660B2 (en) 2006-01-25 2013-11-19 Navilyst Medical, Inc. Valved catheter with power injection bypass
US8257321B2 (en) 2008-05-21 2012-09-04 Navilyst Medical, Inc. Pressure activated valve for high flow rate and pressure venous access applications
US8337470B2 (en) * 2009-01-28 2012-12-25 Angiodynamics, Inc. Three-way valve for power injection in vascular access devices
US8083721B2 (en) 2009-01-29 2011-12-27 Navilyst Medical, Inc. Power injection valve
US8007468B2 (en) 2009-07-13 2011-08-30 Navilyst Medical, Inc. Method to secure an elastic component in a valve
US20110087093A1 (en) * 2009-10-09 2011-04-14 Navilyst Medical, Inc. Valve configurations for implantable medical devices
US9895524B2 (en) 2012-07-13 2018-02-20 Angiodynamics, Inc. Fluid bypass device for valved catheters
US10610678B2 (en) 2016-08-11 2020-04-07 Angiodynamics, Inc. Bi-directional, pressure-actuated medical valve with improved fluid flow control and method of using such
WO2020142698A1 (en) * 2019-01-05 2020-07-09 Foremost Technologies and Products, Inc. High pressure processing of foods and supplements
KR102584576B1 (en) * 2021-04-07 2023-09-27 황일영 Small container, method of deliver materials using the same, and device for mixing materials

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US611520A (en) * 1898-09-27 Bottle for holding spirits or other liquids and aerated waters
DE482319C (en) * 1929-09-11 Eduard Kober Device for marking and cutting of hose lengths for the production of sealing rings for bottles u. like
US2371774A (en) * 1943-03-10 1945-03-20 William A Nosik Pharmaceutical dispensing device
US2549417A (en) * 1949-08-10 1951-04-17 Frederick M Turnbull Syringe ampoule
BE503143A (en) * 1950-05-09
FR1274643A (en) * 1960-09-13 1961-10-27 Capping device for vials intended for extemporaneous preparations
US4396383A (en) * 1981-11-09 1983-08-02 Baxter Travenol Laboratories, Inc. Multiple chamber solution container including positive test for homogenous mixture
US4411662A (en) * 1982-04-06 1983-10-25 Baxter Travenol Laboratories, Inc. Sterile coupling
US4533347A (en) * 1983-12-19 1985-08-06 Warner-Lambert Company Controller for a dual drug delivery system
US4731060A (en) * 1986-11-17 1988-03-15 Catalano Marc L Hydrostatic float valve and intravenous system supplied therewith
US5176275A (en) * 1989-03-27 1993-01-05 Bowie Stuart S Temperature release containers
US5205834A (en) * 1990-09-04 1993-04-27 Moorehead H Robert Two-way outdwelling slit valving of medical liquid flow through a cannula and methods
US5201722A (en) * 1990-09-04 1993-04-13 Moorehead Robert H Two-way outdwelling slit valving of medical liquid flow through a cannula and methods
JP3236287B2 (en) * 1990-11-29 2001-12-10 キヤノン株式会社 Multiprocessor system
US5221268A (en) * 1991-12-06 1993-06-22 Block Medical, Inc. Multiple dose control apparatus
EP0597111A1 (en) * 1992-03-31 1994-05-18 Tokai Corporation Ready-to-heat canned food
US5385545A (en) * 1992-06-24 1995-01-31 Science Incorporated Mixing and delivery system
GB9316317D0 (en) * 1993-08-06 1993-09-22 Smithkline Beecham Plc Novel container
GB9410493D0 (en) * 1994-05-25 1994-07-13 Metal Box Plc Beverage container
FR2730218B1 (en) * 1995-02-06 1997-03-21 Jean Marc Francois Torrollion DEVICE FOR STORING INSULATING A PRODUCT IN A PRESSURIZED PACKAGING AND RELEASING IT AT THE TIME OF ITS OPENING

Also Published As

Publication number Publication date
EP0891179A1 (en) 1999-01-20
JP2000504252A (en) 2000-04-11
JP4132079B2 (en) 2008-08-13
DE69711610T2 (en) 2002-11-28
CA2241076A1 (en) 1998-05-07
BR9706898A (en) 1999-07-20
WO1998018425A1 (en) 1998-05-07
ES2175375T3 (en) 2002-11-16
MX9805191A (en) 1998-10-31
KR19990076875A (en) 1999-10-25
US5865308A (en) 1999-02-02
DE69711610D1 (en) 2002-05-08

Similar Documents

Publication Publication Date Title
EP0891179B1 (en) A system, method and device for controllably releasing a product
US4610684A (en) Flexible container and mixing system for storing and preparing I.V. fluids
US4608043A (en) I.V. fluid storage and mixing system
JP3282817B2 (en) Multi-chamber container
US5257986A (en) Container for the separate sterile storage of at least two substances and for mixing said substances
US10543315B2 (en) Multi-chambered vessels
US10485733B2 (en) Devices and methods for establishing communication between chambers in a multi-chambered vessel
US9902508B2 (en) Delivery device with separate chambers connectable in fluid communication when ready for use, and related method
JP2003531778A (en) Multi-component mixing
JP2003205977A (en) Flexible multi-chamber container
WO2004099028A1 (en) Flexible multichamber mixing container
JP2000191053A (en) Bag body having easily openable separator
EP1011508A1 (en) Constituent delivery system
US4527687A (en) Package
JPH05103820A (en) Medicinal fluid injector
AU735473B2 (en) Multi-compartment rehydrating container
JPH03256872A (en) Container for contents to be mixed
GB2293879A (en) Defrost warning indicator

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980612

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE ES FR GB NL SE

17Q First examination report despatched

Effective date: 20000615

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): DE ES FR GB NL SE

REF Corresponds to:

Ref document number: 69711610

Country of ref document: DE

Date of ref document: 20020508

ET Fr: translation filed
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20021011

Year of fee payment: 6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20021106

Year of fee payment: 6

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2175375

Country of ref document: ES

Kind code of ref document: T3

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20030106

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20031029

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040501

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20040501

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20031029

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20091028

Year of fee payment: 13

Ref country code: DE

Payment date: 20091028

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20091026

Year of fee payment: 13

Ref country code: FR

Payment date: 20091029

Year of fee payment: 13

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20101028

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101102

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20110630

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 69711610

Country of ref document: DE

Effective date: 20110502

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101028

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101029

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110502